Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Our team will review your medical history, symptoms, and lab results to recommend the safest option for you
On May 29, 2026, argenx conducted a phase 3b study is to investigate the efficacy, safety, and tolerability of a continuous regimen of efgartigimod compared with a cyclic regimen in participants with Generalized Myasthenia Gravis (gMG)
The bottle solution is injected directly using ultra-fine needles, making the process virtually painless with minimal swelling
Always consult with your physician or other qualified health providers about medical concerns
More than 10 million of those cases are undiagnosed
:max_bytes(150000):strip_icc()/Health-GettyImages-2190382211-1cdb5299c31943bd92857173e09da74e.jpg)
US$ 22.98
US$ 27.31
US$ 22.53
US$ 28.23
US$ 29.24
US$ 28.81
US$ 24.43
US$ 24.94
US$ 29.80
